Japan's Leading
Medical Services Organization
for Longevity.
Japan's leading Medical Services Organization (MSO) — a structure familiar to healthcare investors — operating 293 clinics across 20+ brands. From a single clinic in Fujisawa in 2000 to 7.06 million customers today, and now expanding into the global Longevity market.
Nasdaq Listed Sep 2024
Symbol
Nasdaq Global Market : SBCPrice
$Market Cap
Change
Shares Outstanding
Volume
Q3 FY2026 Key Figures
Locations
Customers (LTM)
Repeat Rate
EBITDA
EBITDA Margin
Basic EPS
Latest News
Investor Calendar
Investment Highlights
Six reasons SBC is built to compound.
Japan's #1 Aesthetic Healthcare platform
.A highly profitable Medical Services Organization (MSO) model with 7.06MM annual visits, a 73% repeat rate², and a 47% adjusted EBITDA margin
Customers
REPEAT RATE
EBITDA MARGIN
Longevity we already own the hardest piece to build — the platform that delivers treatment
Exceptional service, network accessibility, overwhelming brand trust, high repeat rates, and large case volume reinforce each other in a flywheel that creates a barrier to replication.
Two way global expansion
Importing Longevity know-how from the US and taking Japan's clinic operating model to the US and Asia
AI turns 26 years of data into earnings growth
Using accumulated clinical and customer data with AI to drive revenue growth and greater operating leverage
RePhysical medical infrastructure — increasingly scare in the age of AI —
The ability to deliver care through licensed clinics and physicians cannot easily be replicated
A highly profitable compounding model backed by a strong financial base
Net cash of $154 MM. Pursuing growth investment funded by operating cash flow and sustained EPS growth
Net Cash
Structural Competitive Advantage
A Barrier to Replication Built Over 25 Years
Each element of SBC's competitive position strengthens the others. Exceptional service drives high repeat rates. High repeat rates fund network expansion. A larger network grows brand trust. Brand trust enables premium pricing and case volume — which in turn reinvests into service quality.
This flywheel is why a new entrant cannot replicate SBC's position by simply copying any single element. They would need to replicate the entire system simultaneously — and earn 25 years of customer trust.
FOUNDATIONAL CAPABILITIES POWERING THE FLYWHEEL
Data-Based Management
Strategies leveraging vast customer & case data
Academic Activities
75 doctors as speakers, 28 conferences in FY2025
Integrated Infrastructure
Comprehensive, fast, and low-cost service delivery
Advanced HR Education
Training and manuals ensuring consistent quality
Strategic Vision
A youthful, vital life — through Longevity.
Approaching both appearance and physical wellness is key to living a youthful, vital life. SBC will leverage all its
capabilities to address the Longevity market through four integrated growth strategies.
Aesthetic
Appearance-Based Approach
Longevity
A Youthful, Vital Life
Non-Aesthetic
Physical Wellness Approach
Multi-Brand Strategy in Aesthetic Dermatology
Maximize market share through targeted brand portfolio across SBC, Rize, Gorilla, AHH, and JUN brands.
Non-Aesthetic Business Expansion
Apply aesthetic healthcare expertise to diversify into orthopedics, dentistry, fertility, ophthalmology, and AGA.
Global Business Expansion
Expand aesthetic dermatology clinics to the U.S. and Southeast Asia through M&A and strategic partnerships.
AI-Driven Competitiveness & Cost Reform
Transform clinical and operational data into AI learning resources to build proprietary competitive advantages.
Latest Results
Stay Informed
Get SBC investor updates delivered.
Be the first to receive earnings releases, SEC filings, strategic announcements, and event invitations directly to your inbox. Subscribe by topic — no spam, no marketing.
Contact Us
For inquiries from institutional investors, sell-side analysts, and shareholders, please reach out directly to our Investor Relations team. We typically respond within one business day (JST).
IR Contact
Head of Investor Relations
[email protected]
Media Contact
Corporate Communications
[email protected]
HQ — Americas
United States
HQ — Japan
Shinjuku-ku, Tokyo